TIM50 peptide

  • Check with publisher
  • Published date: July 23, 2019
    • Shirley, New York, United States

TIMM50 (translocase of inner mitochondrial membrane 50 homolog (S. cerevisiae)) is a protein-coding gene. Diseases associated with TIMM50 include spinal muscular atrophy, and muscular atrophy, and among its related super-pathways are Post-translational protein modification. GO annotations related to this gene include RNA binding and protein serine/threonine phosphatase activity.

Result 0 votes
Thomas Schmitt
0 votes

Useful information

  • Avoid scams by acting locally or paying with PayPal
  • Never pay with Western Union, Moneygram or other anonymous payment services
  • Don't buy or sell outside of your country. Don't accept cashier cheques from outside your country
  • This site is never involved in any transaction, and does not handle payments, shipping, guarantee transactions, provide escrow services, or offer "buyer protection" or "seller certification"

Related listings

  • TMPRSS2  peptide

    TMPRSS2 peptide

    Life Sciences Shirley (New York) July 23, 2019 Check with publisher

    This gene encodes a protein that belongs to the serine protease family. The encoded protein contains a type II transmembrane domain, a receptor class A domain, a scavenger receptor cysteine-rich domain and a protease domain. Serine proteases are know...

  • Protein Interaction Analysis Services

    Protein Interaction Analysis Services

    Life Sciences Shirley (New York) June 26, 2019 Check with publisher

    Protein-protein interactions (PPIs) are established when protein molecules physically contact with each other through hydrogen or hydrophobic bonds, Van der Waals forces, ionic forces, or even covalent bonds. This phenomenon underlies a wide range of...

  • Biosimilar Testing Services

    Biosimilar Testing Services

    Life Sciences Shirley (New York) June 26, 2019 Check with publisher

    A biosimilar (also known as follow-on biologic or subsequent entry biologic) is a biologic medical product. Biosimilars are officially approved versions of original "innovator" products, and can be manufactured when the original product's patent expi...